Screening microRNAs as potential prognostic biomarkers for lung adenocarcinoma

References

• Nugent WC, Edney MT, Hammerness PG, et al. Non-small cell lung cancer at the extremes of age: impact on diagnosis and treatment. Ann Thorac Surg. 1997; 63(1):1–12. doi: 10.1016/s0003-4975(96)00745-x.PMID: 8993264.
   Web of Science ®Google Scholar
• Mederos N, Friedlaender A, Peters S, et al. Gender-specific aspects of epidemiology, molecular genetics and outcome: lung cancer. ESMO Open. 2020; 5(Suppl 4):e000796. doi: 10.1136/esmoopen-2020-000796.
   PubMed Web of Science ®Google Scholar
• Ding Y, Zhang L, Guo L, et al. Comparative study on the mutational profile of adenocarcinoma and squamous cell carcinoma predominant histologic subtypes in Chinese non-small cell lung cancer patients. Thorac Cancer. 2020; 11(1):103–112. doi: 10.1111/1759-7714.13208.
   PubMed Web of Science ®Google Scholar
• Gyoba J, Shan S, Roa W, et al. Diagnosing lung cancers through examination of Micro-RNA biomarkers in blood, plasma, serum and sputum: a review and summary of current literature. Int J Mol Sci. 2016;17(4):494. doi: 10.3390/ijms17040494.
   PubMed Web of Science ®Google Scholar
• Subramanian J, Govindan R. Lung cancer in never smokers: a review. J Clin Oncol. 2007;25(5):561–570. PMID: 17290066. doi: 10.1200/JCO.2006.06.8015.
   PubMed Web of Science ®Google Scholar
• Xie D, Marks R, Zhang M, et al. Nomograms predict overall survival for patients with Small-Cell lung cancer incorporating pretreatment peripheral blood markers. J Thorac Oncol. 2015;10(8):1213–1220. PMID: 26200277. doi: 10.1097/JTO.0000000000000585.
   PubMed Web of Science ®Google Scholar
• Li RZ, Fan XX, Duan FG, et al. Proscillaridin a induces apoptosis and suppresses non-small-cell lung cancer tumor growth via calcium-induced DR4 upregulation. Cell Death Dis. 2018;9(6):696. doi: 10.1038/s41419-018-0733-4.
   PubMedGoogle Scholar
• Arbour KC, Riely GJ. Systemic therapy for locally advanced and metastatic non-small cell lung cancer: a review. JAMA. 2019;322(8):764–774. PMID: 31454018. doi: 10.1001/jama.2019.11058.
   PubMed Web of Science ®Google Scholar
• Yekta S, Shih IH, Bartel DP. MicroRNA-directed cleavage of HOXB8 mRNA. Science. 2004;304(5670):594–596. PMID: 15105502. doi: 10.1126/science.1097434.
   PubMed Web of Science ®Google Scholar
• Vasudevan S, Tong Y, Steitz JA. Switching from repression to activation: microRNAs can up-regulate translation. Science. 2007;318(5858):1931–1934. Epub 2007 Nov 29. PMID: 18048652. doi: 10.1126/science.1149460.
   PubMed Web of Science ®Google Scholar
• Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer. 2006;6(4):259–269. PMID: 16557279. doi: 10.1038/nrc1840.
   PubMed Web of Science ®Google Scholar
• Mendell JT. Targeting a long noncoding RNA in breast cancer. N Engl J Med. 2016;374(23):2287–2289. PMID: 27276568. doi: 10.1056/NEJMcibr1603785.
   PubMed Web of Science ®Google Scholar
• Thomson DW, Dinger ME. Endogenous microRNA sponges: evidence and controversy. Nat Rev Genet. 2016;17(5):272–283. doi: 10.1038/nrg.2016.20.
   PubMed Web of Science ®Google Scholar
• Lopez-Rincon A, Martinez-Archundia M, Martinez-Ruiz GU, et al. Automatic discovery of 100-miRNA signature for cancer classification using ensemble feature selection. BMC Bioinformatics. 2019;20(1):480. doi: 10.1186/s12859-019-3050-8.
   PubMed Web of Science ®Google Scholar
• Li X, Shi Y, Yin Z, et al. An eight-miRNA signature as a potential biomarker for predicting survival in lung adenocarcinoma. J Transl Med. 2014;12:159. doi: 10.1186/1479-5876-12-159.
   PubMed Web of Science ®Google Scholar
• Wu ZH, Zhong Y, Zhou T, et al. miRNA biomarkers for predicting overall survival outcomes for head and neck squamous cell carcinoma. Genomics. 2021;113(1 Pt 1):135–141. Epub 2020 Dec 3. PMID: 33279650. doi: 10.1016/j.ygeno.2020.12.002.
   PubMed Web of Science ®Google Scholar
• Bishop JA, Benjamin H, Cholakh H, et al. Accurate classification of non-small cell lung carcinoma using a novel microRNA-based approach. Clin Cancer Res. 2010; 16(2):610–619. Epub 2010 Jan 12. PMID: 20068099. doi: 10.1158/1078-0432.CCR-09-2638.
   PubMed Web of Science ®Google Scholar
• Zhong S, Golpon H, Zardo P, et al. miRNAs in lung cancer. A systematic review identifies predictive and prognostic miRNA candidates for precision medicine in lung cancer. Transl Res. 2021;230:164–196. Epub 2020 Nov 28. PMID: 33253979. doi: 10.1016/j.trsl.2020.11.012.
   PubMed Web of Science ®Google Scholar
• Takikita M, Chung JY, Hewitt SM. Tissue microarrays enabling high-throughput molecular pathology. Curr Opin Biotechnol. 2007;18(4):318–325. Epub 2007 Jul 20. PMID: 17643281. doi: 10.1016/j.copbio.2007.05.007.
   PubMed Web of Science ®Google Scholar
• Gao Z, Liu H, Shi Y, et al. Identification of cancer stem cell molecular markers and effects of Hsa-Mir-21-3p on stemness in esophageal squamous cell carcinoma. Cancers. 2019;11(4): 518. doi: 10.3390/cancers11040518.
   Web of Science ®Google Scholar
• Casadei L, Calore F, Creighton CJ, et al. Exosome-derived mir-25-3p and mir-92a-3p stimulate liposarcoma progression. Cancer Res. 2017;77(14):3846–3856. doi: 10.1158/0008-5472.CAN-16-2984.
   PubMed Web of Science ®Google Scholar
• Kim DH, Park H, Choi YJ, et al. Exosomal mir-1260b derived from non-small cell lung cancer promotes tumor metastasis through the inhibition of Hipk2. Cell Death Dis. 2021;12(8):747. doi: 10.1038/s41419-021-04024-9.
   PubMed Web of Science ®Google Scholar
• Gao S-L, Fan Y, Liu X-D, et al. Circ_0089153 exacerbates breast cancer cells proliferation and metastasis via sponging mir-2467-3p/E2f6. Environ Toxicol. 2022;37(6):1458–1471. PMID: 35225430. doi: 10.1002/tox.23498.
   PubMed Web of Science ®Google Scholar
• Jung CK, Jung S-H, Yim S-H, et al. Predictive micrornas for lymph node metastasis in endoscopically resectable submucosal colorectal cancer. Oncotarget. 2016;7(22):32902–32915. doi: 10.18632/oncotarget.8766.
   PubMedGoogle Scholar
• Koinis F, Kotsakis A, Georgoulias V. Small cell lung cancer (SCLC): no treatment advances in recent years. Transl Lung Cancer Res. 2016;5(1):39–50. doi: 10.3978/j.issn.2218-6751.2016.01.03.
   PubMed Web of Science ®Google Scholar
• Travis WD. Update on small cell carcinoma and its differentiation from squamous cell carcinoma and other non-small cell carcinomas. Mod Pathol. 2012; 25 Suppl 1:S18–S30. PMID: 22214967. doi: 10.1038/modpathol.2011.150.
   PubMedGoogle Scholar
• Russo G, Zegar C, Giordano A. Advantages and limitations of microarray technology in human cancer. Oncogene. 2003;22(42):6497–6507. PMID: 14528274. doi: 10.1038/sj.onc.1206865.[Mismatc]
   PubMed Web of Science ®Google Scholar
• Lee YS, Dutta A. MicroRNAs in cancer. Annu Rev Pathol. 2009;4:199–227. doi: 10.1146/annurev.pathol.4.110807.092222.
   PubMed Web of Science ®Google Scholar
• Zhang X, He X, Liu Y, et al. MiR-101-3p inhibits the growth and metastasis of non-small cell lung cancer through blocking PI3K/AKT signal pathway by targeting MALAT-1. Biomed Pharmacother. 2017;93:1065–1073. Epub 2017 Jul 18. PMID: 28738500. doi: 10.1016/j.biopha.2017.07.005.
   PubMed Web of Science ®Google Scholar
• Duca RB, Massillo C, Dalton GN, et al. MiR-19b-3p and miR-101-3p as potential biomarkers for prostate cancer diagnosis and prognosis. Am J Cancer Res. 2021; 11(6):2802–2820.
   PubMed Web of Science ®Google Scholar
• Cao S, Lin L, Xia X, et al. lncRNA SPRY4-IT1 regulates cell proliferation and migration by sponging miR-101-3p and regulating AMPK expression in gastric cancer. Mol Ther Nucleic Acids. 2019;17:455–464. doi: 10.1016/j.omtn.2019.04.030.
   PubMedGoogle Scholar
• Chava S, Reynolds CP, Pathania AS, et al. miR-15a-5p, miR-15b-5p, and miR-16-5p inhibit tumor progression by directly targeting MYCN in neuroblastoma. Mol Oncol. 2020;14(1):180–196. doi: 10.1002/1878-0261.12588.
   PubMed Web of Science ®Google Scholar
• Luo J, Pan J, Jin Y, et al. MiR-195-5p inhibits proliferation and induces apoptosis of non-small cell lung cancer cells by targeting CEP55. Onco Targets Ther. 2019;12:11465–11474. doi: 10.2147/OTT.S226921.
   PubMed Web of Science ®Google Scholar
• Yan F, Zhao W, Xu X, et al. LncRNA DHRS4-AS1 inhibits the stemness of NSCLC cells by sponging miR-224-3p and upregulating TP53 and TET1. Front Cell Dev Biol. 2020;8:585251. doi: 10.3389/fcell.2020.585251.
   PubMed Web of Science ®Google Scholar
• Peterson SM, Thompson JA, Ufkin ML, et al. Common features of microRNA target prediction tools. Front Genet. 2014; 5:23. doi: 10.3389/fgene.2014.00023.
   PubMed Web of Science ®Google Scholar
• Jiang N, Zou C, Zhu Y, et al. HIF-1ɑ-regulated miR-1275 maintains stem cell-like phenotypes and promotes the progression of LUAD by simultaneously activating Wnt/β-catenin and notch signaling. Theranostics. 2020; 10(6):2553–2570. doi: 10.7150/thno.41120.
   PubMed Web of Science ®Google Scholar
• Wu X, Sui Z, Zhang H, et al. Integrated analysis of lncRNA-Mediated ceRNA network in lung adenocarcinoma. Front Oncol. 2020;10:554759. doi: 10.3389/fonc.2020.554759.
   PubMed Web of Science ®Google Scholar
• Guo Y, Wang G, Wang Z, et al. Reck-notch1 signaling mediates miR-221/222 regulation of lung cancer stem cells in NSCLC. Front Cell Dev Biol. 2021;9:663279. doi: 10.3389/fcell.2021.663279.
   PubMed Web of Science ®Google Scholar
• He H, Song X, Yang Z, et al. Upregulation of KCNQ1OT1 promotes resistance to stereotactic body radiotherapy in lung adenocarcinoma by inducing ATG5/ATG12-mediated autophagy via miR-372-3p. Cell Death Dis. 2020;11(10):883. doi: 10.1038/s41419-020-03083-8.
   PubMed Web of Science ®Google Scholar
• Guo CM, Liu SQ, Sun MZ. miR-429 as biomarker for diagnosis, treatment and prognosis of cancers and its potential action mechanisms: a systematic literature review. Neoplasma. 2020;67(2):215–228. doi: 10.4149/neo_2019_190401N282.
   PubMed Web of Science ®Google Scholar
• Wang A, Zhu J, Li J, et al. Downregulation of KIAA1199 by miR-486-5p suppresses tumorigenesis in lung cancer. Cancer Med. 2020;9(15):5570–5586. doi: 10.1002/cam4.3210.
   PubMed Web of Science ®Google Scholar
• Xue M, Hong W, Jiang J, et al. Circular RNA circ-LDLRAD3 serves as an oncogene to promote non-small cell lung cancer progression by upregulating SLC1A5 through sponging miR-137. RNA Biol. 2020;17(12):1811–1822. doi: 10.1080/15476286.2020.1789819.
   PubMed Web of Science ®Google Scholar
• Luo K, Zhao Y, Liu H, et al. Identification of critical miRNAs as novel diagnostic markers for laryngeal squamous cell carcinoma. Dis Markers. 2022;2022:6858411. doi: 10.1155/2022/6858411.
   PubMed Web of Science ®Google Scholar
• Xie H, Jing R, Liao X, et al. Arecoline promotes proliferation and migration of human HepG2 cells through activation of the PI3K/AKT/mTOR pathway. Hereditas. 2022; 159(1):29. doi: 10.1186/s41065-022-00241-0.
   PubMed Web of Science ®Google Scholar
• Zhang YQ, Chen RL, Shang LQ, et al. Nicotine-induced miR-21-3p promotes chemoresistance in lung cancer by negatively regulating FOXO3a. Oncol Lett. 2022; 24(2):260. doi: 10.3892/ol.2022.13380.
   PubMed Web of Science ®Google Scholar